Gray matter volume deficits in spinocerebellar ataxia: An optimized voxel based morphometric study

Parkinsonism and Related Disorders

Volumn 17, Issue 7, 2011, Pages 521-527

  Goel, Gaurav ^a   Pal, Pramod Kumar ^a   Ravishankar, Shivashankar ^a   Venkatasubramanian, Ganesan ^a   Jayakumar, Peruvumba N ^a   Krishna, Nithin ^a   Purushottam, Meera ^a   Saini, Jitender ^a   Faruq, Mohammed ^b   Mukherji, Mitali ^b   Jain, Sanjeev ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Cerebellum; SCA; Spinocerebellar ataxia; VBM

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CAG REPEAT; CEREBELLUM VERMIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAY MATTER; HEMISPHERE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; BRAIN; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; SPINOCEREBELLAR ATAXIAS;

EID: 79960262015     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.04.008     Document Type: Article

References (29)

1. Schols L., Bauer P., Schmidt T., Schulte T., Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
2. Burk K., Abele M., Fetter M., Dichgans J., Skalej M., Laccone F., et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 1996, 119(Pt. 5):1497-1505.
3. Subramony S.H., Filla A. Autosomal dominant spinocerebellar ataxias ad infinitum?. Neurology 2001, 56:287-289.
4. Klockgether T., Skalej M., Wedekind D., Luft A.R., Welte D., Schulz J.B., et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain 1998, 121(Pt. 9):1687-1693.
5. Murata Y., Kawakami H., Yamaguchi S., Nishimura M., Kohriyama T., Ishizaki F., et al. Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6. Arch Neurol 1998, 55:1348-1352.
6. Murata Y., Yamaguchi S., Kawakami H., Imon Y., Maruyama H., Sakai T., et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 1998, 55:33-37.
7. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
8. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
9. Ginestroni A., Della N.R., Tessa C., Giannelli M., De G.D., Plasmati R., et al. Brain structural damage in spinocerebellar ataxia type 1: a VBM study. J Neurol 2008, 255:1153-1158.
10. Della N.R., Ginestroni A., Tessa C., Salvatore E., De G.D., Plasmati R., et al. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage 2008, 43:10-19.
11. Lukas C., Schols L., Bellenberg B., Rub U., Przuntek H., Schmid G., et al. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study. Neurosci Lett 2006, 408:230-235.
12. Brenneis C., Bosch S.M., Schocke M., Wenning G.K., Poewe W. Atrophy pattern in SCA2 determined by voxel-based morphometry. Neuroreport 2003, 14:1799-1802.
13. Schulz J.B., Borkert J., Wolf S., Schmitz-Hübsch T., Rakowicz M., Mariotti C., et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 2010 Jan 1, 49(1):158-168.
14. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997, 145:205-211.
15. Ananth H., Popescu I., Critchley H.D., Good C.D., Frackowiak R.S., Dolan R.J. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry 2002, 159:1497-1505.
16. Ashburner J., Neelin P., Collins D.L., Evans A., Friston K. Incorporating prior knowledge into image registration. Neuroimage 1997, 6:344-352.
17. Ashburner J., Friston K.J. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999, 7:254-266.
18. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
19. Talairach P., Tournoux J.A. A stereotactic co-planar atlas of the human brain 1988, Thieme, Stuttgart.
20. Genis D., Matilla T., Volpini V., Rosell J., Davalos A., Ferrer I., et al. Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology 1995, 45:24-30.
21. Gilman S., Sima A.A., Junck L., Kluin K.J., Koeppe R.A., Lohman M.E., et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 1996, 39:241-255.
22. Estrada R., Galarraga J., Orozco G., Nodarse A., Auburger G. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 1999, 97:306-310.
23. Della Nave R., Ginestroni A., Tessa C., Cosottini M., Giannelli M., Salvatore E., et al. Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study. Mov Disord 2008, 23:899-903.
24. Durr A., Stevanin G., Cancel G., Duyckaerts C., Abbas N., Didierjean O., et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996, 39:490-499.
25. Jafar-Nejad P., Ward C.S., Richman R., Orr H.T., Zoghbi H.Y. Regional rescue of spinocerebellar ataxia type 1 p.enotypes by 14-3-3{varepsilon} haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration. Proc Natl Acad Sci U S A 2011, 108:2142-2147.
26. Rubinsztein D.C. Lessons from animal models of Huntington's disease. Trends Genet 2002, 18:202-209.
27. Mollersen L., Rowe A.D., Larsen E., Rognes T., Klungland A. Continuous and periodic expansion of CAG repeats in Huntington's disease R6/1 mice. PLoS Genet 2010, 6:e1001242.
28. De Biase I., Rasmussen A., Monticelli A., Al-Mahdawi S., Pook M., Cocozza S., et al. Somatic instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses throughout life. Genomics 2007, 90:1-5.
29. Kaplan S., Itzkovitz S., Shapiro E. A universal mechanism ties genotype to phenotype in trinucleotide diseases. PLoS Comput Biol 2007, 3:e235.